Eslicarbazepine acetate 800 mg Oral Tablet
RxNorm 1482525
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1482525 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: eslicarbazepine acetate 800 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Eslicarbazepine acetate 800 mg Oral Tablet
(Atom ID: 5911613)
PSNPrescribable
Prescribable Name (PSN):
Eslicarbazepine acetate 800 mg Oral Tablet
(Atom ID: 6364572)
PTPrescribable
Designated preferred name (PT):
Eslicarbazepine acetate 800 mg oral tablet
(Atom ID: 12725753)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely eslicarbazepine acetate 800 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 12727208)
Patient Education
Eslicarbazepine
Eslicarbazepine is used in combination with other medications to control focal (partial) seizures (seizures that involve only one part of the brain). Eslicarbazepine is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.